Related Experiment Video
Updated: Jun 6, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma
Jing Zhao1, Ikuko Endoh, Kenneth Hsu
1Inflammation and Infection Research Centre, School of Medical Sciences, University of New South Wales, Sydney, Australia.
S100A8 protein protects against allergic inflammation by reducing mast cell activation and eosinophil infiltration in the lungs. Its antioxidant properties are key to this protective role in conditions like asthma.
Area of Science:
- Immunology
- Pulmonology
- Biochemistry
Background:
- S100A8 is involved in inflammatory disease pathogenesis.
- It is upregulated by Toll-like receptors and corticosteroids.
- S100A8 has antioxidant properties, scavenging oxidants from phagocytes.
Purpose of the Study:
- To investigate the protective role of S100A8 in allergic inflammation.
- To determine if S100A8 modulates mast cell activation and immune cell infiltration in asthma models.
Main Methods:
- In vitro studies using mast cells and IgE-crosslinking.
- In vivo studies using a mouse model of acute asthma.
- Assessed mast cell degranulation, cytokine production, and immune cell infiltration.
- Compared S100A8 with a non-thiol reactive mutant (Cys(41)-Ala S100A8).
Main Results:
- S100A8, but not the mutant, reduced mast cell degranulation and pro-inflammatory cytokine production (IL-6, IL-4, GM-CSF) in vitro.
- S100A8 inhibited intracellular reactive oxygen species (ROS) production, reducing downstream signaling pathways.
- In asthma models, S100A8 decreased mast cell degranulation, eosinophil chemoattractant production (IL-5, eotaxin, MCP-1), and eosinophil infiltration.
- Mucus production was reduced, potentially due to suppressed IL-6 and IL-13.
Conclusions:
- S100A8 plays a protective role in allergic inflammation.
- Its protective effects are dependent on its thiol-scavenging capacity.
- S100A8 modulates mast cell activation, eosinophil recruitment, and scavenges oxidants, offering a potential therapeutic avenue for asthma.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...